Joan H Schiller

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

Robert Gray, R. Gray, J. Schiller, 2006, The New England journal of medicine.

An eHealth system supporting palliative care for patients with non–small cell lung cancer

Ming-Yuan Chih, Kang Namkoong, David H Gustafson, 2013, Cancer.

Predictive and prognostic factors for non-small cell lung cancer--potholes in the road to the promised land.

Adi F Gazdar, Joan H Schiller, 2011, Journal of the National Cancer Institute.

Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.

Chao Huang, M. Socinski, J. Neal, 2018, Lung cancer.

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

David Cella, Karen Kelly, Roy S Herbst, 2003, JAMA.

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

P. Friedman, M. Edelman, E. Vokes, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Thomas J. Smith, Thomas J Smith, Gregory J Riely, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

David Harrington, D. Harrington, J. Krook, 2002, The New England journal of medicine.

New molecularly targeted therapies for lung cancer.

John D Minna, J. Minna, J. Schiller, 2007, The Journal of clinical investigation.

Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.

Andreas Friedl, G. Wilding, A. Friedl, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

Roy S Herbst, Vincent Miller, Rafael Rosell, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.

Martin Marciniak, David M Loesch, C. Obasaju, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.